| BMC Cancer | |
| A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma | |
| Siyu Song1  Zhenying Guo1  Weimin Mao1  Zhongjian Chen1  Chenxi Yang1  Yun Gao1  Ding Wang1  Junping Liu1  | |
| [1] The Cancer Research Institute, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, 310022, Zhejiang, Hangzhou, China;Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, 310022, Zhejiang, Hangzhou, China; | |
| 关键词: Patient-derived xenograft; Malignant pleural mesothelioma; GC-MS; Metabolomics; Ultrasound-guided biopsy; | |
| DOI : 10.1186/s12885-021-08980-5 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundMalignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of misdiagnosis, MPM is rarely studied. Therefore, novel modeling methodology is crucially needed to facilitate MPM research.MethodsA novel patient-derived xenograft (PDX) modeling strategy was designed, which included preliminary screening of patients with pleural thickening using computerized tomography (CT) scan, further reviewing history of disease and imaging by a senior sonographer as well as histopathological analysis by a senior pathologist, and PDX model construction using ultrasound-guided pleural biopsy from MPM patients. Gas chromatography-mass spectrometry-based metabolomics was further utilized for investigating circulating metabolic features of the PDX models. Univariate and multivariate analysis, and pathway analysis were performed to explore the differential metabolites, enriched metabolism pathways and potential metabolic targets.ResultsAfter screening using our strategy, 5 out of 116 patients were confirmed to be MPM, and their specimens were used for modeling. Two PDX models were established successfully. Metabolomics analysis revealed significant metabolic shifts in PDX models, such as dysregulations in amino acid metabolism, TCA cycle and glycolysis, and nucleotide metabolism.ConclusionsTo sum up, we suggested a novel modeling strategy that may facilitate specimen availability for MM research, and by applying metabolomics in this model, several metabolic features were identified, whereas future studies with large sample size are needed.
【 授权许可】
CC BY
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202112042113596ZK.pdf | 14494KB |
PDF